Gilead CSO, COO
Gilead Sciences' Exec VP-Research and Development Norbert Bischofberger will add chief scientific officer to his title, and Chief Financial Officer John Milligan is appointed chief operating officer, the company says March 9. In his new role, Bischofberger will oversee all aspects of Gilead's R&D efforts. Milligan will now manage Gilead's commercial organization, manufacturing, finance and business operations. He will also continue to serve as CFO until a replacement is found...
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.